期刊文献+

结核分枝杆菌CFP21抗原的HLA-A*0201/*03限制性细胞毒T淋巴细胞表位预测

Prediction of HLA-A*0201/*03-restricted cytotoxic T lymphocyte epitopes in Mycobacterium tuberculosis CFP21 antigen
下载PDF
导出
摘要 目的:探寻结核分枝杆菌CFP21抗原的同时针对HLA-A*0201/*03型别的广谱细胞毒T淋巴细胞(CTL)表位。方法:对结核分枝杆菌CFP21抗原的HLA-A*0201候选肽,利用在线数据库预测HLA-A*03限制性的天然表位肽,通过氨基酸置换适当修饰获得对应的改造肽。通过T2A3细胞结合力实验筛选候选肽,用于细胞毒活性实验。结果:在线数据库预测共获得4条母体肽和3条改造肽。结合力实验显示,改造肽p134-1Y2L、p134-1Y2L9L和母体肽p134与HLA-A*03分子均具有较高的结合力。改造肽p134-1Y2L9L和母体肽p134均能诱导CTL反应,但p134诱导出的CTL对靶细胞具有更强的杀伤效应。结论:p134(AVADHVAAV)是同时针对HLA-A*0201/*03型别的广谱CTL表位。 Aim:To explore the HLA-A*0201/*03 cytotoxic T lymphocyte(CTL) epitopes from Mycobacterium tuberculosis CFP21.Methods:The online database was applied to predict the HLA-A*03 restricted natural epitope peptide based on the HLA-A*0201 candidate peptides of CFP21 antigen,and modified epitopes were obtained by amino acid replacement.T2A3 cell line was used to determine the binding affinity of the candidate peptides,and the candidate peptides were selected for subsequent cytotoxicity assay.Results:Four native epitopes and 3 modified epitopes were obtained.The binding affinity of the modified epitope p134-1Y2L,p134-1Y2L9L and the native p134 towards HLA-A*03 molecule was relatively high.Cytotoxicity assay showed that both the modified epitope p134-1Y2L9L and the native peptide p134 could induce potent CTL response,and p134-induced CTLs could potently lyse the peptide-loaded target cells.Conclusion:p134(AVADHVAAV) could be a broad spectrum CTL epitope towards HLA-A*0201/*03.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2012年第1期10-13,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目30872381 30901362
关键词 结核分枝杆菌 CFP21 表位 Mycobacterium tuberculosis CFP21 epitope
  • 相关文献

参考文献4

二级参考文献37

  • 1吴传勇,娄加陶,蒋廷旺,钱,周晔,陈燕,陈波,谷明莉,邓安梅,仲人前.结核杆菌抗原Ag85C的HLA-A*0201限制性CD8^+CTL表位的预测及鉴定[J].第二军医大学学报,2007,28(4):349-354. 被引量:7
  • 2Grover A, Ahmed MF, Verma I, et al. Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immanoprophylactic potential in mouse model[J]. Protein Exp Purif, 2006, 48(2) :274.
  • 3Lee JS, Son JW, Jung SB, et al. Ex vivo responses for interferon-gamma and proinflammatory cytokine secretion to low-molecular-weight antigen MTB12 of Mycobacterium tuberculosis during human tuberculosis [ J ]. Scand J Immunol, 2006, 64(2) :145.
  • 4Malen H, Softeland T, Wiker HG. Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins [J]. Scand J Immunol, 2008, 67(3) :245.
  • 5Aoshi T, Nagata T, Suzuki M, et al. Identification of an HLA-A * 0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPTS1 overlapping peptide screening[J]. Infect lmmun, 2008, 76(4) :1 565.
  • 6Adams HP, Koziol JA. Prediction of binding to MHC class Imolecules [J]. J Immunol Methods, 1995, 185(2) :181.
  • 7Sud D, Bigbee C, Flynn JL, et al. Contribution of CD8^+ T cells to control of Mycobacterium tuberculosis infection [J]. J Immunol, 2006, 176(7) :4 296.
  • 8Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism [J]. Immunogenetics, 1999, 50(3/4) :201.
  • 9Kesmir C, Nussbaum AK, Schild H, et al. Prediction of proteasome cleavage motifs by neural networks [ J ]. Protein Eng, 2002, 15(4) :287.
  • 10Global Tuberculosis Control:Surveillance,Planning,Finacing.WHO report 2004,Geneva,Switzerland,2004.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部